In March 2018, the National Institute for Health and Care Excellence (NICE) updated its guideline (NG87) on diagnosing and managing attention-deficit hyperactivity disorder (ADHD), and its in-house systematic reviews on the efficacy and adverse events of pharmacological treatments for ADHD... To read the full article, log in using your NHS OpenAthens details.